A. Miller, M. Mihm, and J. , Melanoma, New England Journal of Medicine, vol.355, issue.1, pp.51-65, 2006.
DOI : 10.1056/NEJMra052166

V. Ivanov, A. Bhoumik, and Z. Ronai, Death receptors and melanoma resistance to apoptosis, Oncogene, vol.22, issue.20, pp.3152-3161, 2003.
DOI : 10.1038/sj.onc.1206456

P. Hersey, Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma, Current Opinion in Oncology, vol.18, issue.2, pp.189-196, 2006.
DOI : 10.1097/01.cco.0000208794.24228.9f

S. Sapoznik, O. Hammer, R. Ortenberg, M. Besser, and T. Ben-moshe, Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms, Clinical and Developmental Immunology, vol.24, issue.2, 2012.
DOI : 10.1056/NEJMoa1001294

S. Barondes, D. Cooper, M. Gitt, and H. Leffler, Structure and function of a large family of animal lectins, J Biol Chem, vol.269, pp.20807-20810, 1994.

M. Elola, C. Wolfenstein-todel, M. Troncoso, G. Vasta, and G. Rabinovich, Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival, Cellular and Molecular Life Sciences, vol.64, issue.13, pp.1679-1700, 2007.
DOI : 10.1007/s00018-007-7044-8

C. Brewer, M. Miceli, and L. Baum, Clusters, bundles, arrays and lattices: novel mechanisms for lectin???saccharide-mediated cellular interactions, Current Opinion in Structural Biology, vol.12, issue.5, pp.616-639, 2002.
DOI : 10.1016/S0959-440X(02)00364-0

J. Wang, R. Gray, K. Haudek, and R. Patterson, Nucleocytoplasmic lectins, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1673, issue.1-2, pp.75-93, 2004.
DOI : 10.1016/j.bbagen.2004.03.013

F. Liu and G. Rabinovich, Galectins as modulators of tumour progression, Nature Reviews Cancer, vol.19, issue.1, pp.29-41, 2005.
DOI : 10.1038/nrc1275

D. Delacour, A. Koch, and R. Jacob, The Role of Galectins in Protein Trafficking, Traffic, vol.342, issue.10, pp.1405-1418, 2009.
DOI : 10.1111/j.1600-0854.2009.00960.x

URL : https://hal.archives-ouvertes.fr/hal-00493282

G. Rabinovich and M. Toscano, Turning 'sweet' on immunity: galectin???glycan interactions in immune tolerance and inflammation, Nature Reviews Immunology, vol.16, issue.5, pp.338-52, 2009.
DOI : 10.1038/nri2536

P. Madsen, H. Rasmussen, T. Flint, P. Gromov, and T. Kruse, Cloning, expression, and chromosome mapping of human galectin-7, J Biol Chem, vol.270, pp.5823-5829, 1995.

T. Magnaldo, F. Bernerd, and M. Darmon, Galectin-7, a Human 14-kDa S-Lectin, Specifically Expressed in Keratinocytes and Sensitive to Retinoic Acid, Developmental Biology, vol.168, issue.2, pp.259-271, 1995.
DOI : 10.1006/dbio.1995.1078

T. Magnaldo, D. Fowlis, and M. Darmon, Galectin-7, a marker of all types of stratified epithelia, Differentiation, vol.63, issue.3, pp.159-168, 1998.
DOI : 10.1046/j.1432-0436.1998.6330159.x

S. Ueda, I. Kuwabara, and F. Liu, Suppression of Tumor Growth by Galectin-7 Gene Transfer, Cancer Research, vol.64, issue.16, pp.5672-5676, 2004.
DOI : 10.1158/0008-5472.CAN-04-0985

K. Polyak, Y. Xia, J. Zweier, K. Kinzler, and B. Vogelstein, A model for p53- induced apoptosis, Nature, vol.389, issue.6648, pp.300-305, 1997.
DOI : 10.1038/38525

H. Zhu, H. Pei, S. Zeng, J. Chen, and L. Shen, Profiling Protein Markers Associated with the Sensitivity to Concurrent Chemoradiotherapy in Human Cervical Carcinoma, Journal of Proteome Research, vol.8, issue.8, pp.3969-3976, 2009.
DOI : 10.1021/pr900287a

J. Lu, H. Pei, M. Kaeck, and H. Thompson, Gene expression changes associated with chemically induced rat mammary carcinogenesis, Molecular Carcinogenesis, vol.19, issue.2, pp.204-215, 1997.
DOI : 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M

S. Saussez, D. Cucu, C. Decaestecker, C. D. Kaltner, and H. , Galectin 7 (p53-Induced Gene 1): A New Prognostic Predictor of Recurrence and Survival in Stage IV Hypopharyngeal Cancer, Annals of Surgical Oncology, vol.113, issue.7, pp.999-1009, 2006.
DOI : 10.1245/ASO.2006.08.033

M. Demers, T. Magnaldo, and Y. St-pierre, A Novel Function for Galectin-7: Promoting Tumorigenesis by Up-regulating MMP-9 Gene Expression, Cancer Research, vol.65, issue.12, pp.5205-5210, 2005.
DOI : 10.1158/0008-5472.CAN-05-0134

M. Demers, K. Biron-pain, J. Hebert, A. Lamarre, and T. Magnaldo, Galectin-7 in Lymphoma: Elevated Expression in Human Lymphoid Malignancies and Decreased Lymphoma Dissemination by Antisense Strategies in Experimental Model, Cancer Research, vol.67, issue.6, pp.2824-2829, 2007.
DOI : 10.1158/0008-5472.CAN-06-3891

M. Demers, A. Rose, A. Grosset, K. Biron-pain, and L. Gaboury, Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells, The American Journal of Pathology, vol.176, issue.6, pp.3023-3031, 2010.
DOI : 10.2353/ajpath.2010.090876

URL : https://hal.archives-ouvertes.fr/pasteur-00819591

S. Nakahara, N. Oka, and A. Raz, On the role of galectin-3 in cancer apoptosis, Apoptosis, vol.55, issue.2, pp.267-275, 2005.
DOI : 10.1007/s10495-005-0801-y

G. Gendronneau, S. Sidhu, D. Delacour, T. Dang, and C. Calonne, Galectin-7 in the Control of Epidermal Homeostasis after Injury, Molecular Biology of the Cell, vol.19, issue.12, pp.5541-5549, 2008.
DOI : 10.1091/mbc.E08-02-0166

URL : https://hal.archives-ouvertes.fr/hal-00326943

I. Fidler, Biological behavior of malignant melanoma cells correlated to their survival in vivo, Cancer Res, vol.35, pp.218-224, 1975.

P. Robbins, M. El-gamil, Y. Li, G. Zeng, and M. Dudley, Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma, The Journal of Immunology, vol.169, issue.10, pp.6036-6047, 2002.
DOI : 10.4049/jimmunol.169.10.6036

F. Aoudjit, E. Potworowski, and Y. St-pierre, The metastatic characteristics of murine lymphoma cell lines in vivo are manifested after target organ invasion, Blood, vol.91, pp.623-629, 1998.

K. Biron-pain and Y. St-pierre, Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model, Cellular and Molecular Life Sciences, vol.66, issue.5, pp.783-91, 2012.
DOI : 10.1007/s00018-011-0777-4

URL : https://hal.archives-ouvertes.fr/pasteur-00819060

D. Talantov, A. Mazumder, J. Yu, T. Briggs, and Y. Jiang, Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions, Clinical Cancer Research, vol.11, issue.20, pp.7234-7242, 2005.
DOI : 10.1158/1078-0432.CCR-05-0683

A. Smith, K. Hoek, and D. Becker, Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas, Cancer Biology & Therapy, vol.4, issue.9, pp.1018-1029, 2005.
DOI : 10.4161/cbt.4.9.2165

I. Okamoto, C. Pirker, M. Bilban, W. Berger, and D. Losert, Seven Novel and Stable Translocations Associated with Oncogenic Gene Expression in Malignant Melanoma, Neoplasia, vol.7, issue.4, pp.303-311, 2005.
DOI : 10.1593/neo.04514

J. H. Lim, J. W. Park, D. Min, J. S. Chang, and Y. Lee, NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells, Apoptosis, vol.275, issue.5A, pp.411-421, 2007.
DOI : 10.1007/s10495-006-0576-9

M. Ahmed, Regulation of Radiation-Induced Apoptosis by Early Growth Response-1 Gene in Solid Tumors, Current Cancer Drug Targets, vol.4, issue.1, pp.43-52, 2004.
DOI : 10.2174/1568009043481704

Y. St-pierre, C. Campion, and A. Grosset, A distinctive role for galectin-7 in cancer ?, Frontiers in Bioscience, vol.17, issue.1, pp.438-450, 2012.
DOI : 10.2741/3937

URL : https://hal.archives-ouvertes.fr/pasteur-01009758

S. Rorive, B. Eddafali, S. Fernandez, C. Decaestecker, and S. Andre, Changes in Galectin-7 and Cytokeratin-19 Expression during the Progression of Malignancy in Thyroid Tumors: Diagnostic and Biological Implications, Modern Pathology, vol.15, issue.12, pp.1294-1301, 2002.
DOI : 10.1097/01.MP.0000037306.19083.28

X. Zhu, M. Ding, M. Yu, M. Feng, and L. Tan, Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis, BMC Cancer, vol.13, issue.2, p.290, 2010.
DOI : 10.1038/sj.onc.1206631

P. Alves, G. Godoy, D. Gomes, A. Medeiros, and L. De-souza, Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue, Pathology - Research and Practice, vol.207, issue.4, pp.236-240, 2011.
DOI : 10.1016/j.prp.2011.02.004

J. George, A. Srivastava, R. Singh, and Y. Shukla, Cypermethrin exposure leads to regulation of proteins expression involved in neoplastic transformation in mouse skin, PROTEOMICS, vol.23, issue.22, pp.4411-4421, 2011.
DOI : 10.1002/pmic.201100233

C. Villeneuve, L. Baricault, L. Canelle, N. Barboule, and C. Racca, Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells, Molecular Biology of the Cell, vol.22, issue.7, pp.999-1013, 2011.
DOI : 10.1091/mbc.E10-06-0534

H. Ke, V. Parron, R. J. Zhang, J. Akiyama, and S. , BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization, Cell Research, vol.269, issue.4, pp.458-469, 2010.
DOI : 10.1073/pnas.68.11.2799

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848692